« Older Entries

SGX Nifty Indicates Positive Opening; CYIENT Q2 Earnings Beat Consensus on All Fronts

Yesterday, Nifty quickly witnessed selling pressure after opening above 12,000. Massive profit booking was seen across the sectors. Nifty lost almost 300 points following a record 10 days of gains. Volume was higher than the previous session. In the broader market, both the Nifty Midcap and Smallcap were down 1.7% each.

On the sectoral front, all the sectoral indices closed in the red. Nifty Bank (-3.4%) declined the most, followed by other financial related stocks. Barring Nifty Metal (-0.5%), all the sectoral indices declined more than 1%.

Looking forward, we would prefer to see a follow-through day before shifting the market to a Confirmed Uptrend. (A follow-through day is a solid up session, generally a 1.5% or higher gain, with volume being higher than the previous day). Should this occur, the focus will be on ideas that show the best relative strength with good accumulation. Stocks that recover the quickest tend to lead the next run. On the flip side, if Nifty breaches its recent low of 10,790, the market will be moved back to a Downtrend.

Key News

Mindtree (Nse) reported Q2 FY21 results. Net profit advanced 19% q/q to Rs 253.7 crore. Revenue stood at Rs 1,926 crore as against Rs 1,909 crore in Q1 FY21.

Creditaccess Grameen Ltd announced the issue of non-convertible debentures (NCDs) worth Rs 100 crore.

Cyient Ltd (Nse) reported Q2 FY21 results, which beats consensus. Profit jumped 3.1% q/q to Rs 83.9 crore as against Rs 81.4 crore in Q1 FY21, while revenue advanced 1.2% q/q to Rs 1,003.3 crore from Rs 991.7 crore on a q/q basis.

O’Neil Market Condition Report

For the 24 emerging markets tracked by our institutional research team, the market status breakdown is as follows: Confirmed Uptrend, 15%; Rally Attempt, 10%; Uptrend Under Pressure, 50%; Downtrend, 25%.

For the 24 developed markets tracked by our institutional research team, the market status breakdown is as follows: Confirmed Uptrend, 20%; Rally Attempt, 5%; Uptrend Under Pressure, 65%; Downtrend, 10%.

Visit Marketsmith India to Read More About Indian Share Market News, Daily Market Tips, Model Portfolio etc.

Tags:

Getting Balanced Hormones and Protection with Lorna Vanderhaeghe’s Estrosmart

Women all over the world experience painful menstrual cramps, breast lumps, fibroids, cysts, endometriosis, hormonal acne, and uterine thickening. This is mostly caused because the estrogen and the progesterone are not in balance. This can cause a lot of issues which can lead to deadly diseases like cancer. Victims can be experiencing pain that keeps them from working, sleeping, doing household chores, driving, and much more. If you are experiencing this type of pain or discomfort, there is a solution.

Estrosmart by Lorna Vanderhaeghe is designed to maintain the healthy balance between the progesterone and estrogen. It can treat and protect against fibrocystic breasts and detoxifies against toxic estrogens from household and commercial products. It is also know to decrease abnormal cell growth like fibroids, breast lumps, endometriosis, cysts, and thick uterine lining. It can also slow the conversion of good estrogens like 2-hydroxyestone to bad estrogens like 16-hydroxystrone. They have also been known to reduce period discomfort and hormonal acne.

Active ingredients

- Calcium D-Glucarate,150 mg,

- Indole-3-Carbinol,150 mg,

- Green Tea Extract,100 mg,

- Turmeric, 50 mg,

- Di-indolyImethane, 50 mg,

- Rosemary Extract, 25 mg,

- Sulforaphane, 200 mcg

What are the ingredients for?

Calcium D-glucarate detoxifies the body of any toxic or excessive estrogen. Indole-3-carbinole and Diindolylmethane breaks down cancer-causing estrogens. Green Tea Extract is shown to protect against estrogen-related cancers. Curcumin inhibits cancer in all of its form. It is also known to protect against bone loss and helps in the digestive process. A potent antioxidant, rosemary extract protects the cells from cancer-causing agents and slows the growth of cancer cells. Sulforaphane can stimulate the production of enzymes that help in the detoxification of environmental estrogens.

How many do you take?

For period relief, fibrocystic breasts, prevention of hormonal acne, and balanced hormones, adults over the age of twelve can take two capsules a day with food. For endometriosis, cysts, fibroids, and super flowing periods, adults over the age of twelve should take four capsules a day with food.

When you need relief and want to improve your health, Estrosmart is the product that you need. If you are looking for some added proof, go to Vitasave and read the Estrosmart reviews and see for yourself how other people love the product. It has the power to relieve the monthly debilitating pain so that you can function normally. This product is free of sweeteners, colors, preservatives, soy, yeast, wheat, and irrigated rice flour. It is a gluten free product that is also vegan friendly.

Lorna Vanderhaeghe has works very hard to empower women to take back their health. She wants them to be able to give women the products that they need to be their healthiest they can be. Take care of yourself and lessen the pain of monthly menstrual pain. You can get her products and many other natural supplements at Vitasave. They have a huge variety of supplements and dietary needs that will help you maintain your current lifestyle and take on the world with great vitality.

—

Tags:

Global Markets Trade Higher; JLR Sales Increased 50% q/q in Quarter Ended September 30

Yesterday, Nifty gapped up and trended higher to make an intraday high of 11,578. As the day wore on, Nifty succumbed to selling pressure and quickly lost over 120 points and made an intraday low of 11,452. Buying was seen in the second half, which helped the index close above 11,500. On the sectoral front, the majority of sectoral indices advanced. Nifty IT (+3.5%) advanced the most, followed by Nifty Metal and Pharma, which closed 2.6% and 1.7% higher, respectively. On the flip side, Nifty Media (-0.2%), PSU Bank (-0.1%), and Auto (-0.1%) were the decliners. FIIs’ net buying was Rs 237 crore, while DIIs’ net selling was Rs 471 crore.

Looking forward, we would prefer to see a follow-through day before shifting the market to a Confirmed Uptrend. (A follow-through day is a solid up session, generally a 1.5% or higher gain, with volume being higher than the previous day). Should this occur, the focus will be on ideas that show the best relative strength with good accumulation. Stocks that recover the quickest tend to lead the next run. On the flip side, if Nifty breaches its recent low of 10,790, the market will be moved back to a Downtrend.

Key News

Infibeam Avenues Ltd: The company entered into a definitive agreement with Jio Platforms and its affiliates.

Tata Motors: JLR retail sales was up 50% q/q to 1,13,569 vehicles in Q2 FY21, but down 11.9% y/y.

Sobha: In Q2 FY21, the company has achieved a total sales volume of 8,91,700 square feet, valued at Rs 6.90B, with a total average realization of Rs 7,737 per square feet.

O’Neil Market Condition Report

For the 24 emerging markets tracked by our institutional research team, the market status breakdown is as follows: Confirmed Uptrend, 15%; Rally Attempt, 10%; Uptrend Under Pressure, 50%; Downtrend, 25%.

For the 24 developed markets tracked by our institutional research team, the market status breakdown is as follows: Confirmed Uptrend, 20%; Rally Attempt, 5%; Uptrend Under Pressure, 65%; Downtrend, 10%.

Visit Marketsmith India to Read More About Indian Share Market News, Daily Market Tips, Model Portfolio etc.

Tags: